Lead sustainable growth based on field experience...Lee Wook-se, new CEO of Albogen Korea, inaugurated
Sep 02, 2025
|
The new CEO Lee Wook-se is evaluated as a leader with a field-oriented management philosophy and a global sense. He has experienced pharmaceutical sales and organizational operations in general, holding key positions at Chong Kun Dang, Novartis and Merxero. In particular, based on the abundant experience accumulated by both domestic and global pharmaceutical companies, he has demonstrated a broad understanding of the market and balanced leadership.
In his inaugural address, CEO Lee expressed his ambition, saying, "Albogen Korea will fulfill its social responsibilities as a global healthcare company that contributes to the promotion of human health" and "We will lead the company's sustainable growth by combining its field experience, sales philosophy, and transparent ethical management."" In addition, in order to realize the group's core vision of 'Preferred Partner', we will further strengthen our trust with our customers and partners and build a win-win partnership model through innovation," he stressed.
Alvogen Korea, a Korean corporation under the multinational company Lotus Group, has more than 200 products in various areas, from obesity treatment to specialized treatments such as the central nervous system (CNS), kidney, and cardiovascular, and over-the-counter drugs.
Through the appointment of the CEO, we plan to practice transparent and sound management and take a leap forward in domestic and international markets under the leadership of professional managers who understand both the field and the organization, said an official from Albogen Korea.
This article was translated by Naver AI translator.
